ISCHEMIC SYNDROMES AND CYTOPROTECTION (TRIMETAZIDINE)

ISCHEMIC SYNDROMES AND CYTOPROTECTION (TRIMETAZIDINE)

Ischemic syndromes and cytoprotection (trimetazidine).

Saved in:

Bibliographic Details
Main Authors:	A. A. Gorbachenkov, V. V. Hobot
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2001-10-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2062
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

Personalized trimetazidine prescription as a cytoprotective agent in patients with coronary artery disease
by: O. V. Romashchenko
Published: (2021-07-01)

EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE
by: A. V. Shabalin, et al.
Published: (2016-01-01)

Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Mitochondria and Cytoprotection
by: Catherine Brenner, et al.
Published: (2012-01-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

THE ROLE OF HYPOXIA-INDUCED FACTOR-1 (HIF-1) IN CYTOPROTECTION EFFECT IN ISCHEMIC AND PHARMACOLOGIC POSTCONDITIONING
by: N. S. Shcherbak, et al.
Published: (2014-11-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

CYTOPROTECTIVE AND NEUROTROPHIC THERAPY FOR CEREBRAL STROKE
by: M. Yu. Martynov, et al.
Published: (2014-07-01)

A comparative study of the anti-ischemic activity of trimetazidine and the compound ALM-802 under conditions of endothelial dysfunction
by: V. V. Barchukov, et al.
Published: (2019-02-01)

Metabolic (cytoprotective) therapy of menopausal disturbances
by: S. N. Tolstov, et al.
Published: (2011-06-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride
by: Yuen-Ting Cheng, et al.
Published: (2025-03-01)

Myocardial cytoprotection and ischemic myocardial dysfunction correction in stable angina patients after transluminal balloon angioplasty or coronary artery stenting
by: I. G. Gordeev, et al.
Published: (2006-02-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Gastrointestinal Cytoprotection by PPAR𝛾 Ligands
by: Yuji Naito, et al.
Published: (2010-01-01)

Trimetazidine effects on mitochondria energetic activity
by: S. V. Eliseeva, et al.
Published: (2008-12-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

TRIMETAZIDINE MB ROLE IN THE OPTIMISATION OF THE ACUTE CORONARY SYNDROME TREATMENT: EFFECTS ON ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION
by: S. I. Davydov, et al.
Published: (2013-12-01)

CYTOPROTECTIVE THERAPY POTENTIAL IN PATIENTS WITH CHRONIC COR PULMONALE
by: S. A. Surotkina, et al.
Published: (2010-10-01)

The applying of immunohistochemical method for evaluating the cytoprotective effect of antidiabetic drugs
by: S. V. Ivanov
Published: (2018-11-01)

Cardioprotective Effect of Trimetazidine in Cardiac Contusion: Experimental Study
by: O. V. Korpacheva, et al.
Published: (2008-04-01)

THE CHANGES OF THE ELECTROPHYSIOLOGICAL PROPERTIES OF NEURONS BY THE ACTION OF SEVOFLURANE AND THEIR ROLE IN THE MECHANISMS OF PRECONDITIONING AND CYTOPROTECTION
by: A. I. Vislobokov, et al.
Published: (2017-11-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

Mitochondrial Roles and Cytoprotection in Chronic Liver Injury
by: Davide Degli Esposti, et al.
Published: (2012-01-01)

TRIMETAZIDINE AND MILDRONATE AS DIRECT ACTION Β2 - ADRENOSENSIBILIZERS (EXPERIMENTAL EVIDENCE)
by: V. I. Tsirkin, et al.
Published: (2002-02-01)

Synergistic interaction between trimetazidine and ketoprophen in mice
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

Implication of Mitochondrial Cytoprotection in Human Islet Isolation and Transplantation
by: Yong Wang, et al.
Published: (2012-01-01)

Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

The Cytoprotective Effects of Melatonin on Gastric Ulcer: A Rat Model
by: Hela A. Muayad, et al.
Published: (2025-04-01)

JNK3 Is Required for the Cytoprotective Effect of Exendin 4
by: Hélène Ezanno, et al.
Published: (2014-01-01)

Reactive oxygen species production by blood leukocytes and its correction by trimetazidine MB in patients with acute coronary syndrome
by: M. G. Glezer, et al.
Published: (2009-08-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

Gastric Cytoprotection as Basis of Gastrointestinal Mucosa Protection and Repair in Erosive Ulcerative Lesions of Various Aetiologies
by: K. V. Ivashkin, et al.
Published: (2020-12-01)

Cytoprotective effects of curcumin on the state of the intestinal barrier in a model of LPS-induced inflammation
by: V. S. Nedzvetsky, et al.
Published: (2025-03-01)